G587-0253 Screening compound: 6-oxo-N-[(3,4,5-trimethoxyphenyl)methyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide

G587-0253 Screening compound: 6-oxo-N-[(3,4,5-trimethoxyphenyl)methyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide
G587-0253 Screening compound: 6-oxo-N-[(3,4,5-trimethoxyphenyl)methyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G587-0253
6-oxo-N-[(3,4,5-trimethoxyphenyl)methyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G587-0253

Molecular Formula

C23H27N3O5 (C23 H27 N3 O5)

Compound Name

6-oxo-N-[(3,4,5-trimethoxyphenyl)methyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide

IUPAC name

6-oxo-N-[(345-trimethoxyphenyl)methyl]-5H6H6aH7H8H9H10H-pyrido[12-a]quinoxaline-3-carboxamide

SMILES

COc1cc(CNC(c(cc2)cc(N3)c2N(CCCC2)C2C3=O)=O)cc(OC)c1OC

InChI

InChI=1S/C23H27N3O5/c1-29-19-10-14(11-20(30-2)21(19)31-3)13-24-22(27)15-7-8-17-16(12-15)25-23(28)18-6-4-5-9-26(17)18/h7-8,10-12,18H,4-6,9,13H2,1-3H3,(H,24,27)(H,25,28)/t18-/m0/s1

InChI Key

SEOWSDGAXWXLLG-SFHVURJKSA-N

MDL Number (MFCD)

MFCD15021356

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

425.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.545

Distribution Coefficient, logD

2.544

Water Solubility, LogSw

-3.08

Polar Surface Area

74.958

Acid Dissociation Constant (pKa)

10.28

Base Dissociation Constant (pKb)

-0.16

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

G587-0253 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Mechanism of action:
  • PPI modulators
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G587-0253 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G587-0253?
Check Price and Availability of G587-0253, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G587-0253 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G587-0253
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G587-0253
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G587-0253 available by request